IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION EMEND® aprepitant capsules This leaflet is part III of a three-part “Product Monograph”

First Page		Document Content
Date: 2014-09-29 16:21:44 Patient safety Organofluorides Dow Jones Industrial Average Merck & Co. Readington New Jersey Aprepitant Adverse effect Prescription medication Pharmaceutical drug Medicine Pharmacology Health		IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION EMEND® aprepitant capsules This leaflet is part III of a three-part “Product Monograph” Document is deleted from original location. Use the Download Button below to download from the Web Archive. Download Document from Web Archive File Size: 176,87 KB

Document is deleted from original location. Use the Download Button below to download from the Web Archive.